healthday12h
FDA Approves Susvimo for Diabetic Macular Edema
Susvimo is the first and only FDA-approved treatment shown to maintain vision in people with diabetic macular edema with ...
Too Old to Operate1d
Impact of Dupilumab on Skin Protein and Metabolite Composition in AD
The following is a summary of “Longitudinal integrated proteomic and metabolomic skin changes in atopic dermatitis patients ...
Business Wire1d
FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes-Related Blindness
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...
Zoetis Adds Warnings to Label for Dog Pain Drug
The animal-health company added warnings about side effects such as seizures and paralysis to the label for Librela.
News Medical5d
UIC scientists redesign asparaginase to minimize leukemia treatment side effects
University of Illinois Chicago scientists have redesigned a treatment for the most common pediatric leukemia to eliminate its severe side effects, like blood clots and liver damage.
Nature6d
US drug agency approves potent painkiller — the first non-opioid in decades
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.